TAOPING INC (TAOP)

VGG8675V1278 - Common Stock

0.3548  +0.01 (+1.95%)

After market: 0.343 -0.01 (-3.33%)

Fundamental Rating

2

Taking everything into account, TAOP scores 2 out of 10 in our fundamental rating. TAOP was compared to 84 industry peers in the IT Services industry. TAOP has a bad profitability rating. Also its financial health evaluation is rather negative. TAOP is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

TAOP had positive earnings in the past year.
In the past year TAOP has reported a negative cash flow from operations.
TAOP had negative earnings in each of the past 5 years.
In the past 5 years TAOP always reported negative operating cash flow.

1.2 Ratios

Looking at the Return On Assets, with a value of 4.99%, TAOP is in the better half of the industry, outperforming 64.63% of the companies in the same industry.
TAOP has a Return On Equity of 10.73%. This is in the better half of the industry: TAOP outperforms 68.29% of its industry peers.
TAOP has a Return On Invested Capital (4.43%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.99%
ROE 10.73%
ROIC 4.43%
ROA(3y)-15.81%
ROA(5y)-22.75%
ROE(3y)-43.57%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 3.99%, TAOP perfoms like the industry average, outperforming 56.10% of the companies in the same industry.
The Operating Margin of TAOP (3.18%) is comparable to the rest of the industry.
TAOP has a worse Gross Margin (21.39%) than 78.05% of its industry peers.
TAOP's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.18%
PM (TTM) 3.99%
GM 21.39%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-13.28%
GM growth 5Y-13.42%

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so TAOP is destroying value.
The number of shares outstanding for TAOP has been increased compared to 1 year ago.
Compared to 5 years ago, TAOP has more shares outstanding
Compared to 1 year ago, TAOP has a worse debt to assets ratio.

2.2 Solvency

TAOP has an Altman-Z score of -6.35. This is a bad value and indicates that TAOP is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -6.35, TAOP is not doing good in the industry: 93.90% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.52 indicates that TAOP is somewhat dependend on debt financing.
TAOP has a Debt to Equity ratio (0.52) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z -6.35
ROIC/WACC0.62
WACC7.14%

2.3 Liquidity

TAOP has a Current Ratio of 1.50. This is a normal value and indicates that TAOP is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of TAOP (1.50) is comparable to the rest of the industry.
A Quick Ratio of 1.33 indicates that TAOP should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.33, TAOP is not doing good in the industry: 60.98% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.33

4

3. Growth

3.1 Past

TAOP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.29%, which is quite impressive.
Looking at the last year, TAOP shows a very strong growth in Revenue. The Revenue has grown by 37.49%.
TAOP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.40% yearly.
EPS 1Y (TTM)114.29%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%111.8%
Revenue 1Y (TTM)37.49%
Revenue growth 3Y51.55%
Revenue growth 5Y13.4%
Sales Q2Q%28.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 0.56 indicates a rather cheap valuation of TAOP.
100.00% of the companies in the same industry are more expensive than TAOP, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 28.96, TAOP is valued rather cheaply.
Industry RankSector Rank
PE 0.56
Fwd PE N/A

4.2 Price Multiples

TAOP's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. TAOP is cheaper than 96.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 0.45

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

TAOP does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

TAOPING INC

NASDAQ:TAOP (11/21/2024, 8:00:01 PM)

After market: 0.343 -0.01 (-3.33%)

0.3548

+0.01 (+1.95%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap2.35M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 0.56
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.99%
ROE 10.73%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.18%
PM (TTM) 3.99%
GM 21.39%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.25
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.5
Quick Ratio 1.33
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)114.29%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next YN/A
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)37.49%
Revenue growth 3Y51.55%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y